Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| COGNEX CORPCGNX · Entity 3527 | Director | February 22, 2023 | February 23, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
COGNEX CORP
Report date February 22, 2023 · Filed February 23, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 35,500 |
Ending reported balance
After 2023-02-23 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2023-02-22 · Exercise / conversion · Acquired 854 · Balance 36,354 Row 2 · 2023-02-23 · Sale · Disposed 854 · Balance 35,500 F1: These shares were disposed of in an open market sale pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2025-02-22 | Direct | 3,415 |
Reported balance
After 2023-02-22 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2023-02-22 · Exercise / conversion · Disposed 854 · Balance 3,415 F2: Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock. F3: The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (February 22, 2022), respectively. |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2024-02-16 | Direct | 1,519 |
Reported balance
Holding disclosure · report date 2023-02-22 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 1,519 |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $50.94 · Expires 2030-02-18 | Direct | 13,800 |
Reported balance
Holding disclosure · report date 2023-02-22 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 13,800 |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $51.49 · Expires 2029-02-19 | Direct | 10,400 |
Reported balance
Holding disclosure · report date 2023-02-22 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 10,400 |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $56.44 · Expires 2028-02-20 | Direct | 2,600 |
Reported balance
Holding disclosure · report date 2023-02-22 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 2,600 |
Filing footnotes · ownership attribution and instrument terms
F1: These shares were disposed of in an open market sale pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
F2: Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock.
F3: The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (February 22, 2022), respectively.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 26, 2019 Filed Feb 26, 2019 18:41 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionCommon Stock | 15,000 | $7.67 | $115,012.50 |
DisclosureSEC source: 0001401616-19-000001 · edgardoc.xml · nonDerivative · entry 1 KRANTZ THEODOR · CIK 0001401616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 19:50 UTC | COGNEX CORP CGNX · Entity 3527 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 26,000 | $0.00 Strike: $51.49 | $0.00 |
DisclosureSEC source: 0001438093-19-000006 · edgardoc.xml · derivative · entry 2 KRANTZ THEODOR · CIK 0001401616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,000 Underlying: Common Stock · 26,000 shares Expires 2029-02-19 Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 17:56 UTC | COGNEX CORP CGNX · Entity 3527 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 13,000 | $0.00 Strike: $56.44 | $0.00 |
DisclosureSEC source: 0001401616-18-000001 · edgardoc.xml · derivative · entry 2 KRANTZ THEODOR · CIK 0001401616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,000 Underlying: Common Stock · 13,000 shares Expires 2028-02-20 Read SEC document |
| November 09, 2017 Filed Nov 13, 2017 13:44 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 7,500 | $0.00 Strike: $15.34 | $0.00 |
DisclosureSEC source: 0001401616-17-000012 · edgardoc.xml · derivative · entry 6 KRANTZ THEODOR · CIK 0001401616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2021-02-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 09, 2017 Filed Nov 13, 2017 13:44 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 7,500 | $0.00 Strike: $8.88 | $0.00 |
DisclosureSEC source: 0001401616-17-000012 · edgardoc.xml · derivative · entry 5 KRANTZ THEODOR · CIK 0001401616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires 2020-06-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 09, 2017 Filed Nov 13, 2017 13:44 UTC | COGNEX CORP CGNX · Entity 3527 | SaleCommon Stock | 7,500 | $134.05 | $1,005,366.00 |
DisclosureSEC source: 0001401616-17-000012 · edgardoc.xml · nonDerivative · entry 4 KRANTZ THEODOR · CIK 0001401616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,750 Read SEC document |
| November 09, 2017 Filed Nov 13, 2017 13:44 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionCommon Stock | 7,500 | $15.34 | $115,012.50 |
DisclosureSEC source: 0001401616-17-000012 · edgardoc.xml · nonDerivative · entry 3 KRANTZ THEODOR · CIK 0001401616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 09, 2017 Filed Nov 13, 2017 13:44 UTC | COGNEX CORP CGNX · Entity 3527 | SaleCommon Stock | 7,500 | $134.05 | $1,005,366.00 |
DisclosureSEC source: 0001401616-17-000012 · edgardoc.xml · nonDerivative · entry 2 KRANTZ THEODOR · CIK 0001401616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,750 Read SEC document |
| November 09, 2017 Filed Nov 13, 2017 13:44 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionCommon Stock | 7,500 | $8.88 | $66,600.00 |
DisclosureSEC source: 0001401616-17-000012 · edgardoc.xml · nonDerivative · entry 1 KRANTZ THEODOR · CIK 0001401616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 14, 2017 Filed Aug 15, 2017 17:43 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 6,000 | $0.00 Strike: $9.35 | $0.00 |
DisclosureSEC source: 0001401616-17-000010 · edgardoc.xml · derivative · entry 6 KRANTZ THEODOR · CIK 0001401616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,000 shares Expires 2018-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 14, 2017 Filed Aug 15, 2017 17:43 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 3,750 | $0.00 Strike: $8.88 | $0.00 |
DisclosureSEC source: 0001401616-17-000010 · edgardoc.xml · derivative · entry 5 KRANTZ THEODOR · CIK 0001401616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 3,750 shares Expires 2020-06-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 14, 2017 Filed Aug 15, 2017 17:43 UTC | COGNEX CORP CGNX · Entity 3527 | SaleCommon Stock | 6,000 | $103.70 | $622,211.40 |
DisclosureSEC source: 0001401616-17-000010 · edgardoc.xml · nonDerivative · entry 4 KRANTZ THEODOR · CIK 0001401616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,750 Read SEC document |
| August 14, 2017 Filed Aug 15, 2017 17:43 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionCommon Stock | 6,000 | $9.35 | $56,100.00 |
DisclosureSEC source: 0001401616-17-000010 · edgardoc.xml · nonDerivative · entry 3 KRANTZ THEODOR · CIK 0001401616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 14, 2017 Filed Aug 15, 2017 17:43 UTC | COGNEX CORP CGNX · Entity 3527 | SaleCommon Stock | 3,750 | $103.90 | $389,608.50 |
DisclosureSEC source: 0001401616-17-000010 · edgardoc.xml · nonDerivative · entry 2 KRANTZ THEODOR · CIK 0001401616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,750 Read SEC document |
| August 14, 2017 Filed Aug 15, 2017 17:43 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionCommon Stock | 3,750 | $8.88 | $33,300.00 |
DisclosureSEC source: 0001401616-17-000010 · edgardoc.xml · nonDerivative · entry 1 KRANTZ THEODOR · CIK 0001401616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 06, 2017 Filed Jun 7, 2017 15:10 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 7,500 | $0.00 Strike: $9.35 | $0.00 |
DisclosureSEC source: 0001401616-17-000008 · edgardoc.xml · derivative · entry 3 KRANTZ THEODOR · CIK 0001401616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 7,500 shares Expires 2018-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 06, 2017 Filed Jun 7, 2017 15:10 UTC | COGNEX CORP CGNX · Entity 3527 | SaleCommon Stock | 7,500 | $96.09 | $720,695.25 |
DisclosureSEC source: 0001401616-17-000008 · edgardoc.xml · nonDerivative · entry 2 KRANTZ THEODOR · CIK 0001401616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,750 Read SEC document |
| June 06, 2017 Filed Jun 7, 2017 15:10 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionCommon Stock | 7,500 | $9.35 | $70,125.00 |
DisclosureSEC source: 0001401616-17-000008 · edgardoc.xml · nonDerivative · entry 1 KRANTZ THEODOR · CIK 0001401616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 18:25 UTC | COGNEX CORP CGNX · Entity 3527 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 13,000 | $0.00 Strike: $76.78 | $0.00 |
DisclosureSEC source: 0001401616-17-000001 · edgardoc.xml · derivative · entry 4 KRANTZ THEODOR · CIK 0001401616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,000 Underlying: Common Stock · 13,000 shares Expires 2027-02-21 Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 18:25 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $11.61 | $0.00 |
DisclosureSEC source: 0001401616-17-000001 · edgardoc.xml · derivative · entry 3 KRANTZ THEODOR · CIK 0001401616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2017-05-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 18:25 UTC | COGNEX CORP CGNX · Entity 3527 | SaleCommon Stock | 20,000 | $76.57 | $1,531,474.00 |
DisclosureSEC source: 0001401616-17-000001 · edgardoc.xml · nonDerivative · entry 2 KRANTZ THEODOR · CIK 0001401616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,750 Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 18:25 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionCommon Stock | 20,000 | $11.61 | $232,200.00 |
DisclosureSEC source: 0001401616-17-000001 · edgardoc.xml · nonDerivative · entry 1 KRANTZ THEODOR · CIK 0001401616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 02, 2011 Filed Feb 26, 2019 18:41 UTC | COGNEX CORP CGNX · Entity 3527 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $8.40 | $0.00 |
DisclosureSEC source: 0001401616-19-000001 · edgardoc.xml · derivative · entry 6 KRANTZ THEODOR · CIK 0001401616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2021-11-02 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.